The Saudi Arabia Diabetic Foot Ulcer Treatment Market was valued at USD 36.3 million in 2024, and is projected to reach USD 54.6 million by 2030, rising at a CAGR of 7.06%. Major factors contributing to the growth of Saudi Arabia diabetic foot ulcer treatment industry include, growing cases of diabetes, growing government initiatives and technological advancements in wound care, including bioengineered skin substitutes, negative pressure wound therapy (NPWT), and others.
The rising prevalence of diabetes in Saudi Arabia has significantly heightened the risk of developing diabetic foot ulcers. According to the World Health Organization, the country is projected to be among the top five nations with the highest prevalence of type 2 diabetes mellitus by 2030. This growing burden of diabetes directly contributes to an increase in diabetes-related complications, including foot ulcers. A study published by the National Center for Biotechnology Information (NCBI) highlights that diabetic foot ulcers are the leading cause of lower limb amputations in Saudi Arabia. The risk of ulceration and subsequent amputation increases as diabetic patients age and as the duration of their condition extends, with the likelihood increasing by two to four times over time. This growing rate further necessitates effective treatment to manage diabetic foot ulcers and reduce associated complications.
Another major factor propelling the market for diabetic foot ulcer treatment in Saudi Arabia is the increasing investment in healthcare infrastructure and advanced medical technologies. The Saudi government, as part of its Vision 2030 initiative, is prioritizing healthcare advancements, leading to improved access to specialized wound care treatments. In addition, the growing presence of multinational medical device companies and collaborations with local healthcare providers are enhancing the availability of innovative treatment options. The expansion of specialized diabetes care centers and the integration of advanced therapies, such as regenerative medicine and smart wound dressings, are further driving the market’s growth.
Lifestyle changes have a significant impact on the increasing prevalence of diabetes and, in turn, the rising cases of diabetic foot ulcers in Saudi Arabia. A sedentary lifestyle, poor dietary habits, and a growing obesity rate are major contributors to the worsening of diabetes-related complications. Limited physical activity and high consumption of processed and sugar-rich foods contribute to insulin resistance, increasing the risk of type 2 diabetes and its associated conditions, including foot ulcers. As a result, the need for effective diabetic foot ulcer treatments is growing, fueling the demand for advanced wound care solutions in the country.
This product will be delivered within 1-3 business days.
The rising prevalence of diabetes in Saudi Arabia has significantly heightened the risk of developing diabetic foot ulcers. According to the World Health Organization, the country is projected to be among the top five nations with the highest prevalence of type 2 diabetes mellitus by 2030. This growing burden of diabetes directly contributes to an increase in diabetes-related complications, including foot ulcers. A study published by the National Center for Biotechnology Information (NCBI) highlights that diabetic foot ulcers are the leading cause of lower limb amputations in Saudi Arabia. The risk of ulceration and subsequent amputation increases as diabetic patients age and as the duration of their condition extends, with the likelihood increasing by two to four times over time. This growing rate further necessitates effective treatment to manage diabetic foot ulcers and reduce associated complications.
Another major factor propelling the market for diabetic foot ulcer treatment in Saudi Arabia is the increasing investment in healthcare infrastructure and advanced medical technologies. The Saudi government, as part of its Vision 2030 initiative, is prioritizing healthcare advancements, leading to improved access to specialized wound care treatments. In addition, the growing presence of multinational medical device companies and collaborations with local healthcare providers are enhancing the availability of innovative treatment options. The expansion of specialized diabetes care centers and the integration of advanced therapies, such as regenerative medicine and smart wound dressings, are further driving the market’s growth.
Lifestyle changes have a significant impact on the increasing prevalence of diabetes and, in turn, the rising cases of diabetic foot ulcers in Saudi Arabia. A sedentary lifestyle, poor dietary habits, and a growing obesity rate are major contributors to the worsening of diabetes-related complications. Limited physical activity and high consumption of processed and sugar-rich foods contribute to insulin resistance, increasing the risk of type 2 diabetes and its associated conditions, including foot ulcers. As a result, the need for effective diabetic foot ulcer treatments is growing, fueling the demand for advanced wound care solutions in the country.
Saudi Arabia Diabetic Foot Ulcer Treatment Market Report Segmentation
This report forecasts revenue growth at the country and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the Saudi Arabia diabetic foot ulcer treatment market report based on treatment, ulcer type, end-use, and regionTreatment Outlook (Revenue, USD Million, 2018-2030)
- Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
- Biologics
- Growth Factors
- Skin Grafts
- Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotic Medications
- Others
Ulcer Type Outlook (Revenue, USD Million, 2018-2030)
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
End-use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Ambulatory surgery centers
- Homecare
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope
Chapter 4. Saudi Arabia Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis
Chapter 5. Saudi Arabia Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis
Chapter 6. Saudi Arabia Diabetic Foot Ulcer Treatment Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Saudi Arabia Diabetic Foot Ulcer Treatment market report include:- ConvaTec, Group Plc
- 3M Health Care
- Coloplast Corp.
- Smith & Nephew Plc
- B Braun Melsungen AG
- Medline Industries, LP.
- Molnlycke Health Care AB
- Medtronic Plc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 36.3 Million |
| Forecasted Market Value ( USD | $ 54.6 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Saudi Arabia |
| No. of Companies Mentioned | 8 |
